Ascendis Pharma Cash Flow from Operating Activities 2015-2025 | ASND
Ascendis Pharma cash flow from operating activities for the twelve months ending March 31, 2025 was $-0.763B, a 45.75% decline year-over-year.
- Ascendis Pharma annual cash flow from operating activities for 2024 was $-0.331B, a 34.5% decline from 2023.
- Ascendis Pharma annual cash flow from operating activities for 2023 was $-0.506B, a 3.15% decline from 2022.
- Ascendis Pharma annual cash flow from operating activities for 2022 was $-0.522B, a 5.7% increase from 2021.